Claudia Zamaly Ferreira Hernández
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Claudia Zamaly Ferreira Hernández has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Andres Felipe Herrera Homez
Avances en Estrategias Basadas en Imágenes para la Detección Temprana del Melanoma Amelanótico Validación Clínica y Perspectivas Internacionales Hospital de Alta Especialidad Quality Consulting /ieccmexico.com/publishing un artículo de acceso abierto distribuido Bicentenario de la Independencia Pontificia Universidad Javeriana Cali EPS Sanitas Universidad Anáhuac México Pontificia Universidad Javeriana Instituto de Educación Capacitación y Certificación de México. https
2 shared publications - Hillary Yahiry Mejía Montiel
Servicios Médicos Integrales Populares S.A
2 shared publications - María Camila Fontecha Garzón
Hospital de Alta Especialidad Bicentenario de la Independencia Universidad Autonoma de Guadalajara Servicios Médicos Integrales Populares Fundación Universitaria Sanitas Pontificia Universidad Javeriana Pontificia Universidad Católica del Ecuador Instituto de Educación Capacitación y Certificación de México
2 shared publications - Ana Gabriela Rangel Galvan
Universidad El Bosque
1 shared publication - Andrea Cristina Naranjo Calvachi
Hospital Gineco Obstétrico Pediátrico de Nueva Aurora Luz Elena Arismendi
1 shared publication - Carolina Paola Ortiz Valdés
Hospital de Alta Especialidad Bicentenario de la Independencia ISSSTE
1 shared publication
Latest Publications
- 12 December 2025
- Published by Quality Consulting Instituto de Educación Capacitación y Certificación de México in IECCMEXICO
- Vol. 3 (1)
Integrated Mechanisms of Cutaneous Immunity: From Barrier Dysfunction to Neuroimmune Crosstalk in Inflammatory Skin Disease
Cutaneous immunity operates through a complex integration of structural, microbial, cellular, and neuroimmune mechanisms that collectively determine the skin’s ability to maintain homeostasis and respond to injury or inflammation. This review synthesizes contemporary evidence on epidermal barrier dysfunction, microbiome dysbiosis, antigen-presenting cell networks, tissue-resident memory T cells, and neuroimmune signaling to construct a comprehensive model explaining the pathophysiology of major inflammatory dermatoses, including atopic dermatitis, psoriasis, and allergic contact dermatitis. Key findings highlight barrier impairment as an initiating factor in immune activation, microbial imbalance—particularly Staphylococcus aureus overgrowth—as a powerful amplifier of inflammatory responses, and specialized immune circuits as central drivers of chronicity. Neuroimmune interactions, although less frequently explored, emerge as critical contributors to persistent pruritus and symptom exacerbation. The integration of these mechanisms provides a unified framework that enhances understanding of disease heterogeneity and supports the development of targeted, context-specific approaches relevant to diverse populations such as those in Mexico, Colombia, and Ecuador. This multidimensional perspective reaffirms the skin as a fully active immune organ and underscores the value of coordinated strategies that address structural integrity, microbial ecology, immune regulation, and neural pathways.
- 12 December 2025
- Published by Quality Consulting Instituto de Educación Capacitación y Certificación de México in IECCMEXICO
- Vol. 3 (1)
Integrated Mechanisms of Cutaneous Immunity: From Barrier Dysfunction to Neuroimmune Crosstalk in Inflammatory Skin Disease
Cutaneous immunity operates through a complex integration of structural, microbial, cellular, and neuroimmune mechanisms that collectively determine the skin’s ability to maintain homeostasis and respond to injury or inflammation. This review synthesizes contemporary evidence on epidermal barrier dysfunction, microbiome dysbiosis, antigen-presenting cell networks, tissue-resident memory T cells, and neuroimmune signaling to construct a comprehensive model explaining the pathophysiology of major inflammatory dermatoses, including atopic dermatitis, psoriasis, and allergic contact dermatitis. Key findings highlight barrier impairment as an initiating factor in immune activation, microbial imbalance—particularly Staphylococcus aureus overgrowth—as a powerful amplifier of inflammatory responses, and specialized immune circuits as central drivers of chronicity. Neuroimmune interactions, although less frequently explored, emerge as critical contributors to persistent pruritus and symptom exacerbation. The integration of these mechanisms provides a unified framework that enhances understanding of disease heterogeneity and supports the development of targeted, context-specific approaches relevant to diverse populations such as those in Mexico, Colombia, and Ecuador. This multidimensional perspective reaffirms the skin as a fully active immune organ and underscores the value of coordinated strategies that address structural integrity, microbial ecology, immune regulation, and neural pathways.
- 8 October 2025
- Published by Quality Consulting Instituto de Educación Capacitación y Certificación de México in International Science Journal
- Vol. 2 (2)
Microbial–Host Interactions in Dermatologic Inflammation: Ecological, Immunological, and Clinical Perspectives
Inflammatory skin diseases are increasingly understood through the lens of the cutaneous microbiome, a dynamic ecosystem whose interactions with the host shape immune responses, barrier integrity, and clinical disease expression. This review synthesizes evidence from two decades of research to examine how microbial composition, functional dysbiosis, and host–microbe crosstalk contribute to the pathophysiology of atopic dermatitis, psoriasis, acne, rosacea, and Malassezia-associated dermatoses. The findings demonstrate that innate immune mechanisms—particularly barrier components, antimicrobial peptides, and pattern recognition receptors—form the primary interface between the microbiome and the host, while disease-specific adaptive pathways (Th2 in atopic dermatitis, Th17 in psoriasis) define distinct inflammatory phenotypes. Temporal trends reveal a rapid expansion of microbiome research beginning in the late 2010s, driven by advances in sequencing and molecular immunology, while thematic analysis highlights an imbalance between mechanistic studies and the still limited development of microbiome-based therapies. The review also identifies a critical gap concerning the underrepresentation of diverse populations, especially in regions such as Mexico, Colombia, and Ecuador, where environmental and cultural factors significantly influence microbial ecology. Collectively, the evidence underscores the microbiome’s central role in shaping cutaneous inflammation and emphasizes the need for geographically inclusive research and translational innovation to support future dermatologic practice.
- 8 October 2025
- Published by Quality Consulting Instituto de Educación Capacitación y Certificación de México in International Science Journal
- Vol. 2 (2)
Microbial–Host Interactions in Dermatologic Inflammation: Ecological, Immunological, and Clinical Perspectives
Inflammatory skin diseases are increasingly understood through the lens of the cutaneous microbiome, a dynamic ecosystem whose interactions with the host shape immune responses, barrier integrity, and clinical disease expression. This review synthesizes evidence from two decades of research to examine how microbial composition, functional dysbiosis, and host–microbe crosstalk contribute to the pathophysiology of atopic dermatitis, psoriasis, acne, rosacea, and Malassezia-associated dermatoses. The findings demonstrate that innate immune mechanisms—particularly barrier components, antimicrobial peptides, and pattern recognition receptors—form the primary interface between the microbiome and the host, while disease-specific adaptive pathways (Th2 in atopic dermatitis, Th17 in psoriasis) define distinct inflammatory phenotypes. Temporal trends reveal a rapid expansion of microbiome research beginning in the late 2010s, driven by advances in sequencing and molecular immunology, while thematic analysis highlights an imbalance between mechanistic studies and the still limited development of microbiome-based therapies. The review also identifies a critical gap concerning the underrepresentation of diverse populations, especially in regions such as Mexico, Colombia, and Ecuador, where environmental and cultural factors significantly influence microbial ecology. Collectively, the evidence underscores the microbiome’s central role in shaping cutaneous inflammation and emphasizes the need for geographically inclusive research and translational innovation to support future dermatologic practice.